Literature DB >> 1506272

Autoradiographic analysis of radiolabeled anti-carcinoembryonic antigen monoclonal antibody CEA102 in colorectal cancer using computed radiography.

T Satoh1, T Watanabe, M Tadokoro, J Sakamoto, H Murayama, K Itoh, S Sakuma, H Takagi.   

Abstract

Anti-carcinoembryonic antigen monoclonal antibody (MAb) CEA102 was produced by immunization with purified CEA and the specific accumulation of radiolabeled CEA102 in colorectal cancers was investigated by autoradiography of surgical specimens using Fuji Computed Radiography (FCR). Five patients with colorectal cancer were injected intravenously with 131I-labeled intact CEA102 or its F(ab')2. Primary tumor and liver metastases were successfully detected by external scanning with a gamma camera in 4 cases. Autoradiographic study of the surgical specimens using FCR showed predominant localization of 131I-labeled CEA102 in primary tumors and liver metastases in all cases. Even a small liver metastasis (0.5 cm) was clearly visualized in the autoradiogram by FCR. The pixel distribution curves of the density of the respective tissues in the autoradiograms by FCR showed the heterogeneity of the distribution of administered radiolabeled MAb in individual tumors, but the density of the tumors was higher than that of the normal tissues. In the quantitative distribution analysis of CEA102, the uptake of the primary tumor (mean 1.10%ID/kg) was ten-fold greater than that of the normal colon mucosa (mean 0.10%ID/kg). These results revealed that the application of MAb has great potential in radioimmunodetection as well as in antibody-directed therapy.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1506272      PMCID: PMC5918825          DOI: 10.1111/j.1349-7006.1992.tb00118.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  21 in total

1.  Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.

Authors:  S M Hsu; L Raine; H Fanger
Journal:  J Histochem Cytochem       Date:  1981-04       Impact factor: 2.479

2.  Immunoscintigraphy of colorectal cancer with an antibody to epithelial membrane antigen (EMA).

Authors:  C Y Yiu; L A Baker; B R Davidson; M Ward; K Roberts; G Clarke; C Ward; J Westwood; P B Boulos; C G Clark
Journal:  Dis Colon Rectum       Date:  1990-02       Impact factor: 4.585

Review 3.  Imaging of colorectal carcinoma with radiolabeled antibodies.

Authors:  D M Goldenberg; H Goldenberg; R M Sharkey; R E Lee; E Higgenbotham-Ford; J A Horowitz; T C Hall; C M Pinsky; H J Hansen
Journal:  Semin Nucl Med       Date:  1989-10       Impact factor: 4.446

4.  Colorectal carcinoma metastases: detection with In-111-labeled monoclonal antibody CCR 086.

Authors:  H H Abdel-Nabi; G Levine; L M Lamki; J L Murray; W N Tauxe; A N Shah; Y Z Patt; R J Doerr; H A Klein; J Gona
Journal:  Radiology       Date:  1990-07       Impact factor: 11.105

5.  Pharmacokinetics of a mouse/human chimeric monoclonal antibody (C-17-1A) in metastatic adenocarcinoma patients.

Authors:  J M Trang; A F LoBuglio; R H Wheeler; E B Harvey; L Sun; J Ghrayeb; M B Khazaeli
Journal:  Pharm Res       Date:  1990-06       Impact factor: 4.200

6.  Imaging of colon carcinoma with 111-indium-labeled anti-CEA monoclonal antibodies (Indacea) prior to surgery.

Authors:  J D Beatty; V J Philben; B G Beatty; L E Williams; R J Paxton; J E Shively; R B Duda; W G Vlahos; J L Werner; K Sheibani
Journal:  J Surg Oncol       Date:  1987-10       Impact factor: 3.454

7.  Colorectal tumors: scintigraphy with In-111 anti-CEA monoclonal antibody and correlation with surgical, histopathologic, and immunohistochemical findings.

Authors:  H H Abdel-Nabi; A N Schwartz; G Goldfogel; J A Ortman-Nabi; D M Matsuoka; M W Unger; D G Wechter
Journal:  Radiology       Date:  1988-03       Impact factor: 11.105

8.  Immunohistochemical localization of CA 19-9 and CEA in pancreatic carcinoma and associated diseases.

Authors:  T Ichihara; H Nagura; A Nakao; J Sakamoto; T Watanabe; H Takagi
Journal:  Cancer       Date:  1988-01-15       Impact factor: 6.860

9.  Preoperative imaging of colorectal carcinoma with 111In-labeled anticarcinoembryonic antigen monoclonal antibody.

Authors:  J D Beatty; R B Duda; L E Williams; K Sheibani; R J Paxton; B G Beatty; V J Philben; J L Werner; J E Shively; W G Vlahos
Journal:  Cancer Res       Date:  1986-12       Impact factor: 12.701

10.  Immunoscintigraphy of adenocarcinomas by means of radiolabeled F(ab')2 fragments of an anti-carcinoembryonic antigen monoclonal antibody: a multicenter study.

Authors:  A G Siccardi; G L Buraggi; L Callegaro; A C Colella; P G De Filippi; G Galli; G Mariani; R Masi; R Palumbo; P Riva
Journal:  Cancer Res       Date:  1989-06-01       Impact factor: 12.701

View more
  1 in total

1.  Imaging of recurrent intestinal carcinoma with indium-111-labeled anti-carcinoembryonic antigen monoclonal antibody CEA102.

Authors:  K Nakada; J Sakamoto; T Watanabe; K Itoh; S Akiyama; H Takagi
Journal:  Jpn J Cancer Res       Date:  1997-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.